Search details
1.
Discovery of novel DNA-damaging agents through phenotypic screening for DNA double-strand break.
Cancer Sci
; 114(3): 1108-1117, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36385507
2.
Functional evaluation of BRCA1/2 variants of unknown significance with homologous recombination assay and integrative in silico prediction model.
J Hum Genet
; 68(12): 849-857, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37731132
3.
BRCA1 transports the DNA damage signal for CDDP-induced centrosome amplification through the centrosomal Aurora A.
Cancer Sci
; 113(12): 4230-4243, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36082621
4.
The BRCA2 missense mutation K2497R suppressed self-degradation and increased ATP production and cell proliferation.
Biochem Biophys Res Commun
; 590: 27-33, 2022 01 29.
Article
in English
| MEDLINE | ID: mdl-34968781
5.
BRCA2 represses the transcriptional activity of pS2 by E2-ERα.
Biochem Biophys Res Commun
; 588: 75-82, 2022 01 15.
Article
in English
| MEDLINE | ID: mdl-34952473
6.
Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer.
Cancer Sci
; 112(1): 454-464, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33075187
7.
Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample.
Cancer Sci
; 112(3): 1310-1319, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33421217
8.
CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivity.
Biochem Biophys Res Commun
; 550: 56-61, 2021 04 23.
Article
in English
| MEDLINE | ID: mdl-33684621
9.
Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.
Int J Cancer
; 145(9): 2488-2495, 2019 11 01.
Article
in English
| MEDLINE | ID: mdl-30963570
10.
Crosstalk of DNA double-strand break repair pathways in poly(ADP-ribose) polymerase inhibitor treatment of breast cancer susceptibility gene 1/2-mutated cancer.
Cancer Sci
; 109(4): 893-899, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29427345
11.
Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer.
Cancer Sci
; 109(8): 2567-2575, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29908105
12.
Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells.
Mol Cell
; 37(5): 714-27, 2010 Mar 12.
Article
in English
| MEDLINE | ID: mdl-20227374
13.
BRCA1 gene: function and deficiency.
Int J Clin Oncol
; 23(1): 36-44, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-28884397
14.
FKBP51 regulates cell motility and invasion via RhoA signaling.
Cancer Sci
; 108(3): 380-389, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-28032931
15.
Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.
Cancer Sci
; 108(11): 2287-2294, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28796317
16.
LAMC2 is a predictive marker for the malignant progression of leukoplakia.
J Oral Pathol Med
; 46(3): 223-231, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-27529842
17.
[Molecular Diagnosis and Treatment of HBOC Syndrome].
Gan To Kagaku Ryoho
; 44(2): 102-106, 2017 Feb.
Article
in Japanese
| MEDLINE | ID: mdl-28223667
18.
RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.
Int J Cancer
; 139(4): 803-11, 2016 08 15.
Article
in English
| MEDLINE | ID: mdl-27004837
19.
Integrative cancer genomics in the era of precision cancer medicine.
J Hum Genet
; 66(9): 843, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34429508
20.
THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma.
J Oral Pathol Med
; 45(10): 730-739, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-26850833